Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VPC 23019 is a competitive antagonist at the S1P1 and S1P3 receptors (pKi= 7.86 and 5.93, respectively). It is also an agonist at the S1P4 and S1P5 receptors (pEC50= 6.58 and 7.07, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 664.00 | |
50 mg | 6-8 weeks | $ 863.00 | |
100 mg | 6-8 weeks | $ 1,290.00 |
Description | VPC 23019 is a competitive antagonist at the S1P1 and S1P3 receptors (pKi= 7.86 and 5.93, respectively). It is also an agonist at the S1P4 and S1P5 receptors (pEC50= 6.58 and 7.07, respectively). |
Targets&IC50 | S1P1:(pEC50)6.58 , S1P1:(pki)7.86 , S1P3:5.93(pki), S1P3:7.07 |
Molecular Weight | 372.4 |
Formula | C17H29N2O5P |
CAS No. | 449173-19-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VPC 23019 449173-19-7 GPCR/G Protein LPL Receptor S1P Receptor VPC23019 inhibit VPC-23019 Lysophospholipid Receptor Inhibitor inhibitor